v2.4.1.9
Collaborations (Tables)
12 Months Ended
Dec. 31, 2014
Erbitux [Member]  
Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table Text Block]
The following table summarizes our revenue recognized with respect to Erbitux:
 
2014
 
2013
 
2012
Net product sales
$
46.1

 
$
58.5

 
$
76.4

Collaboration and other revenue
327.2

 
315.2

 
320.6

Total revenue
$
373.3

 
$
373.7

 
$
397.0

Exenatide [Member]  
Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table Text Block]
The following table summarizes the revenue and other income recognized with respect to exenatide for the years ended December 31, 2013 and 2012:
 
2013
 
2012
Net product sales
$
133.1

 
$
207.8

Collaboration and other revenue

 
70.1

Total revenue
$
133.1

 
$
277.9

 
 
 
 
Income related to termination of the exenatide collaboration with Amylin(1)
$
495.4

 
$
787.8